ES2120180T3 - Sal de potasio de derivado bifenilmetano y medicamento que lo contiene. - Google Patents

Sal de potasio de derivado bifenilmetano y medicamento que lo contiene.

Info

Publication number
ES2120180T3
ES2120180T3 ES95907860T ES95907860T ES2120180T3 ES 2120180 T3 ES2120180 T3 ES 2120180T3 ES 95907860 T ES95907860 T ES 95907860T ES 95907860 T ES95907860 T ES 95907860T ES 2120180 T3 ES2120180 T3 ES 2120180T3
Authority
ES
Spain
Prior art keywords
compound
potassium salt
medicinal product
containing medicinal
mono
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES95907860T
Other languages
English (en)
Inventor
Terukage Hirata
Nobuya Sakae
Koichi Tamura
Masayasu Okuhira
Hirotaka Amano
Masaharu Yokomoto
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Wakunaga Pharmaceutical Co Ltd
Original Assignee
Wakunaga Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wakunaga Pharmaceutical Co Ltd filed Critical Wakunaga Pharmaceutical Co Ltd
Application granted granted Critical
Publication of ES2120180T3 publication Critical patent/ES2120180T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D285/00—Heterocyclic compounds containing rings having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by groups C07D275/00 - C07D283/00
    • C07D285/01—Five-membered rings
    • C07D285/02—Thiadiazoles; Hydrogenated thiadiazoles
    • C07D285/04—Thiadiazoles; Hydrogenated thiadiazoles not condensed with other rings
    • C07D285/08—1,2,4-Thiadiazoles; Hydrogenated 1,2,4-thiadiazoles
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/10—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a carbon chain containing aromatic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
    • C07D263/02—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
    • C07D263/30—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D263/34—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D263/48—Nitrogen atoms not forming part of a nitro radical
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D277/32—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D277/38—Nitrogen atoms
    • C07D277/42—Amino or imino radicals substituted by hydrocarbon or substituted hydrocarbon radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/60—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings condensed with carbocyclic rings or ring systems
    • C07D277/62—Benzothiazoles
    • C07D277/68—Benzothiazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 2
    • C07D277/82—Nitrogen atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

LA PRESENTE INVENCION SE REFIERE AL 2-[[5-ETIL-3-[2''-(1HTETRAZOL-5-IL)BIFENIL-4-IL]METIL-1,3,4-TIADIAZOLIN-2-ILIDEN]AMINOCARBONIL]-1-CICLOPENTANOCARBOXILATO MONO O DIPOTASICO, UNA COMPOSICION FARMACEUTICA QUE CONTIENE EL COMPUESTO, USO DEL COMPUESTO PARA FARMACOS Y UN METODO TERAPEUTICO PARA LAS ENFERMEDADES CIRCULATORIAS POR LA ADMINISTRACION DEL COMPUESTO. LA SAL MONO O DIPOTASICA DEL COMPUESTO TIENE UNA POTENTE ACTIVIDAD ANTAGONISTA DE LA ANGIOTENSINA II Y UN EFECTO ANTIHIPERTENSOR Y TAMBIEN TIENE ALTA BIOUTILIDAD CUANDO SE ADMINISTRA ORALMENTE, DE MANERA QUE ES UTIL COMO UN FARMACO.
ES95907860T 1994-02-10 1995-02-08 Sal de potasio de derivado bifenilmetano y medicamento que lo contiene. Expired - Lifetime ES2120180T3 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP1622094 1994-02-10
JP12873994 1994-06-10

Publications (1)

Publication Number Publication Date
ES2120180T3 true ES2120180T3 (es) 1998-10-16

Family

ID=26352497

Family Applications (1)

Application Number Title Priority Date Filing Date
ES95907860T Expired - Lifetime ES2120180T3 (es) 1994-02-10 1995-02-08 Sal de potasio de derivado bifenilmetano y medicamento que lo contiene.

Country Status (10)

Country Link
EP (1) EP0744402B1 (es)
KR (1) KR970700672A (es)
CN (1) CN1140450A (es)
AT (1) ATE169014T1 (es)
CA (1) CA2181260A1 (es)
DE (1) DE69503760T2 (es)
DK (1) DK0744402T3 (es)
ES (1) ES2120180T3 (es)
GR (1) GR3027777T3 (es)
WO (1) WO1995021837A1 (es)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK0782996T3 (da) * 1994-09-20 1999-09-20 Wakunaga Seiyaku Kk Fremgangsmåde til fremstilling af N-biphenylmethylthiadiazolinderivat eller salt deraf og mellemprodukt til fremstilling af
EP0842932A4 (en) * 1995-06-27 1998-11-25 Wakunaga Seiyaku Kk METHOD FOR PRODUCING TETRAZOLYL-BIPHENYLMETHANE DERIVATIVES

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5326776A (en) * 1992-03-02 1994-07-05 Abbott Laboratories Angiotensin II receptor antagonists
KR950702544A (ko) * 1992-08-11 1995-07-29 구사이 요시히로 비페닐메탄 유도체 및 이를 함유하는 약제
DK0782996T3 (da) * 1994-09-20 1999-09-20 Wakunaga Seiyaku Kk Fremgangsmåde til fremstilling af N-biphenylmethylthiadiazolinderivat eller salt deraf og mellemprodukt til fremstilling af

Also Published As

Publication number Publication date
EP0744402A1 (en) 1996-11-27
CN1140450A (zh) 1997-01-15
KR970700672A (ko) 1997-02-12
WO1995021837A1 (fr) 1995-08-17
AU1591295A (en) 1995-08-29
DE69503760D1 (de) 1998-09-03
AU685586B2 (en) 1998-01-22
DE69503760T2 (de) 1998-12-17
EP0744402B1 (en) 1998-07-29
GR3027777T3 (en) 1998-11-30
DK0744402T3 (da) 1999-05-03
ATE169014T1 (de) 1998-08-15
CA2181260A1 (en) 1995-08-17
EP0744402A4 (en) 1997-03-26

Similar Documents

Publication Publication Date Title
TNSN04246A1 (fr) Derives d'heteroarylamides benzocondenses de thienopyridines utiles comme agents therapeutiques, compositions pharmaceutiques les contenant et methodes pour leur utilisation
ES2117642T3 (es) Preparado farmaceutico que contiene n-glicofuroles y n-etilen glicoles.
TNSN05165A1 (fr) Derives de pyrrolopyrimidine
PT828724E (pt) Diaril-5-oxigenadas-2-(5h)-furanonas comoinibidoras de cox-2
DE122006000051I1 (de) Ester der 5-Aminolevulins{ure als Mittel zur Photosensibillisierung in der Chemotherapie
ES2178430T3 (es) Utilizacion de composiciones farmaceuticas gelificables en parodontologia.
MA28011A1 (fr) Derives de piperazine et leur utilisation en tant qu'agents therapeutiques
GEP20002298B (en) Benzimidazole Derivatives, Method of Their Production, Pharmaceutical Composition Containing the Same and Method for Its Treatment
HUP0302635A2 (hu) Valpronsav foszfolipidszármazékai és ezek keveréke
DE69429328D1 (de) N-(3-piperidinylcarbonyl)-b-alanin derivate als paf-antagonisten
ES2120180T3 (es) Sal de potasio de derivado bifenilmetano y medicamento que lo contiene.
DE69217613T2 (de) Stickstoff enthaltende bizyklische Derivate, Verfahren zu ihrer Herstellung und diese enthaltende pharmazeutische Zubereitungen
BG101709A (en) New applications of lysozyme dimer
DE10299023I2 (de) Antineoplastisch wirkender und den antineoplastischen effekt verstärkender wirkstoff
DK1492539T3 (da) Statin-terapi til forögelse af kognitiv funktion
RU94032792A (ru) Применение 5нтiа - антагонистов для прекращения использования табака
NO304518B1 (no) Benzimidazoler, anvendelse derav for fremstilling av et medikament, samt farmas°ytiske preparater som omfatter dem
DE69328585T2 (de) Neue Alkaloidderivate, ihre Verwendung und diese enthaltende pharmazeutische Formulierungen
GEP20043356B (en) Compounds Useful For Treatment or Prevention of Diseases Mediated By Alpha- 2B-Adrenoceptor
ATE242766T1 (de) Neue derivate von benzoylalkyl-1,2,3,6- tetrahydropyridinen
TH16370A (th) สารประกอบไดแอริล
MD940244A (ro) Derivaţi noi ai tetrazolului, procedeu de obţinere a lor şi compoziţie farmaceutică pe baza lor
KR890000089A (ko) 신장 질환 치료제

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 744402

Country of ref document: ES